Tigermed Completes Acquisition of Japanese CRO Micron
Tigermed (HNGZY), a global clinical research solutions provider, has completed the acquisition of Micron, a Japanese Contract Research Organization (CRO) specializing in medical imaging and clinical trial services. Founded in 2005, Micron brings nearly two decades of expertise with over 160 employees and has supported more than 250 clients, contributing to over 40 drug approvals.
As Japan's first imaging CRO, Micron will be integrated into Tigermed Japan, enhancing the company's medical imaging capabilities across the Asia-Pacific region. The acquisition leverages Micron's mature service team, regional expertise, and pioneering practices in imaging biomarkers and AI-powered imaging support.
Tigermed (HNGZY), fornitore globale di soluzioni per la ricerca clinica, ha completato l'acquisizione di Micron, un'organizzazione giapponese di ricerca a contratto (CRO) specializzata in imaging medico e servizi per studi clinici. Fondata nel 2005, Micron vanta quasi due decenni di esperienza, conta oltre 160 dipendenti e ha supportato più di 250 clienti, contribuendo all'approvazione di oltre 40 farmaci.
In quanto prima CRO di imaging in Giappone, Micron sarà integrata in Tigermed Japan, potenziando le capacità dell'azienda nel campo dell'imaging medico nell'area Asia-Pacifico. L'acquisizione sfrutta il team di servizi consolidato di Micron, la competenza regionale e le pratiche innovative nell'uso di biomarcatori di imaging e nel supporto all'imaging basato sull'intelligenza artificiale.
Tigermed (HNGZY), proveedor global de soluciones para investigación clínica, ha completado la adquisición de Micron, una Organización de Investigación por Contrato (CRO) japonesa especializada en imagen médica y servicios de ensayos clínicos. Fundada en 2005, Micron aporta casi dos décadas de experiencia, cuenta con más de 160 empleados y ha apoyado a más de 250 clientes, contribuyendo a la aprobación de más de 40 medicamentos.
Como la primera CRO de imagen en Japón, Micron se integrará en Tigermed Japan, mejorando las capacidades de la compañía en imagen médica en la región Asia-Pacífico. La adquisición aprovecha el equipo de servicios maduro de Micron, su experiencia regional y sus prácticas pioneras en biomarcadores de imagen y soporte de imagen impulsado por inteligencia artificial.
Tigermed (HNGZY)는 글로벌 임상 연구 솔루션 제공업체로서, 의료 영상 및 임상 시험 서비스에 특화된 일본 계약 연구 기관(CRO)인 Micron의 인수를 완료했습니다. 2005년에 설립된 Micron은 거의 20년의 전문성을 보유하고 있으며, 160명 이상의 직원을 두고 250개 이상의 고객을 지원하며 40건 이상의 신약 승인에 기여했습니다.
일본 최초의 영상 CRO인 Micron은 Tigermed Japan에 통합되어 아시아 태평양 지역에서 회사의 의료 영상 역량을 강화할 예정입니다. 이번 인수는 Micron의 숙련된 서비스 팀, 지역 전문성, 영상 바이오마커 및 AI 기반 영상 지원 분야의 선도적 실무를 활용합니다.
Tigermed (HNGZY), fournisseur mondial de solutions pour la recherche clinique, a finalisé l'acquisition de Micron, une organisation japonaise de recherche sous contrat (CRO) spécialisée dans l'imagerie médicale et les services d'essais cliniques. Fondée en 2005, Micron apporte près de deux décennies d'expertise, compte plus de 160 employés et a soutenu plus de 250 clients, contribuant à l'approbation de plus de 40 médicaments.
En tant que première CRO d'imagerie au Japon, Micron sera intégré à Tigermed Japan, renforçant ainsi les capacités de l'entreprise en imagerie médicale dans la région Asie-Pacifique. Cette acquisition tire parti de l'équipe de service expérimentée de Micron, de son expertise régionale et de ses pratiques pionnières dans les biomarqueurs d'imagerie et le soutien à l'imagerie assistée par intelligence artificielle.
Tigermed (HNGZY), ein globaler Anbieter von Lösungen für klinische Forschung, hat die Übernahme von Micron abgeschlossen, einer japanischen Contract Research Organization (CRO), die auf medizinische Bildgebung und klinische Studien spezialisiert ist. Micron wurde 2005 gegründet, verfügt über fast zwei Jahrzehnte Erfahrung, beschäftigt mehr als 160 Mitarbeiter und hat über 250 Kunden unterstützt, was zu mehr als 40 Arzneimittelzulassungen beigetragen hat.
Als Japans erste Imaging-CRO wird Micron in Tigermed Japan integriert, wodurch die medizinischen Bildgebungsfähigkeiten des Unternehmens in der Asien-Pazifik-Region gestärkt werden. Die Übernahme nutzt das erfahrene Serviceteam von Micron, regionale Expertise sowie innovative Praktiken im Bereich Bildgebungs-Biomarker und KI-gestützte Bildgebungsunterstützung.
- Acquisition expands Tigermed's presence in the strategic Japanese and Asia-Pacific markets
- Adds over 160 specialized employees and the largest imaging expert team in Asia
- Brings proven track record with 250+ clients and 40+ successful drug approvals
- Strengthens medical imaging capabilities with AI-powered technology and imaging biomarkers expertise
- Integration challenges may arise from merging different corporate cultures and operational systems
- Potential regulatory complexities in Japanese healthcare market
Founded in 2005 and headquartered in
As the first imaging CRO in
Following the acquisition, Micron will be integrated into Tigermed's global network as a key entity under Tigermed Japan. Leveraging mature service team and deep regional expertise from Micron, as well as its worldwide operational layout, Tigermed will enhance its coverage across
"It's a great honor to join Tigermed," said Mr. Hiroaki Suzuki, President and Co-founder of Micron. "Micron is committed to human health by supporting research activities in the medical field through utilizing imaging technologies. We believe our 20 years of medical imaging experience and expertise will become a strong support to Tigermed in this sector. And Tigermed's global presence and resources will open new vision for Micron for building a broader platform and opportunity for worldwide expansion."
"We are delighted to welcome Micron to the Tigermed family," said Mr. Michael Wen, Co-President of Tigermed. "Micron's unique strengths in technology and proven track record will be of great value to Tigermed's business expansion in
About Micron
Micron, Inc. was established in 2005 and is headquartered in
About Tigermed
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are collaborating with over 3,600 customers and committed to moving their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 180 locations with over 10,000 employees across
View original content to download multimedia:https://www.prnewswire.com/news-releases/tigermed-completes-acquisition-of-japanese-cro-micron-302515674.html
SOURCE Tigermed
FAQ
What company did Tigermed (HNGZY) acquire in July 2025?
How many employees and clients does Micron bring to Tigermed?
What is the strategic importance of Tigermed's Micron acquisition?
Who will lead Micron after the Tigermed acquisition?
What specialized services does Micron bring to Tigermed?
